Yttrium-90 radioembolization of liver tumors: what do the images tell us?
Pavel Singh,Gopinathan Anil +1 more
Reads0
Chats0
TLDR
This review provides a comprehensive description of the different findings seen in post-treatment scans, with the aim of facilitating appropriate radiological interpretation of post-TARE pathologic changes, notwithstanding their existing limitations.Abstract:
Transarterial radioembolization (TARE) with yttrium 90 microspheres is an increasingly popular therapy for both primary and secondary liver malignancies. TARE entails delivery of β-particle brachytherapy and embolization of the tumor vasculature. The consequent biological sequelae are distinct from those of other transarterial therapies for liver tumors, as reflected in the often baffling post-treatment imaging features. As the clinical use of TARE is increasing, more diverse post-treatment radiological findings are encountered with variable overlap among treatment response, residual disease, reactionary changes and complications. Thus, post-TARE image interpretation is challenging. This review provides a comprehensive description of the different findings seen in post-treatment scans, with the aim of facilitating appropriate radiological interpretation of post-TARE pathologic changes, notwithstanding their existing limitations.read more
Citations
More filters
Journal ArticleDOI
Radioembolization of Colorectal Liver Metastases: Indications, Technique, and Outcomes.
TL;DR: Indications, contraindications, preprocedure evaluation, activity prescription, follow-up, outcomes, and complications of radioembolization of colorectal liver metastases are discussed.
Journal ArticleDOI
Expected and Unexpected Imaging Findings after 90Y Transarterial Radioembolization for Liver Tumors.
TL;DR: Correct treatment planning is essential to obtaining good results with TARE, as this treatment invariably results in some degree of irradiation of normal liver parenchyma, inducing different radiologic findings that may affect follow-up image interpretation and response evaluation.
Journal ArticleDOI
Follow-up after radiological intervention in oncology: ECIO-ESOI evidence and consensus-based recommendations for clinical practice.
Monique Maas,Regina G. H. Beets-Tan,Jean-Yves Gaubert,Fernando Gomez Munoz,Paul Habert,Lisa G. Klompenhouwer,Paulo Vilares Morgado,Niklaus Schaefer,François Cornelis,Stephen B. Solomon,Denise van der Reijd,José Ignacio Bilbao +11 more
TL;DR: Recommendations that can be used in clinical practice to perform the follow-up of patients with liver, lung, and renal cancer who were treated with interventional locoregional therapies are presented.
Journal ArticleDOI
Imaging Evaluation Following 90Y Radioembolization of Liver Tumors: What Radiologists Should Know
TL;DR: The current concepts for assessing tumor response, common post-treatment imaging features, and associated complications following radioembolization are discussed.
Journal ArticleDOI
Evaluation of liver tumour response by imaging.
Jules Gregory,Jules Gregory,Marco Dioguardi Burgio,Marco Dioguardi Burgio,Giuseppe Corrias,Giuseppe Corrias,Valérie Vilgrain,Valérie Vilgrain,Maxime Ronot,Maxime Ronot +9 more
TL;DR: This clinical review focuses on the progress made in the evaluation of liver tumours on imaging, discussing the rationale for this approach, addressing challenges and controversies in the field, and suggesting possible future developments.
References
More filters
Journal ArticleDOI
New Guidelines to Evaluate the Response to Treatment in Solid Tumors
Patrick Therasse,Susan G. Arbuck,Elizabeth Eisenhauer,Jantien Wanders,Richard Kaplan,Larry Rubinstein,Jaap Verweij,Martine Van Glabbeke,Allan T. van Oosterom,Michaele C. Christian,S. Gwyther +10 more
TL;DR: A model by which a combined assessment of all existing lesions, characterized by target lesions and nontarget lesions, is used to extrapolate an overall response to treatment is proposed, which is largely validated by the Response Evaluation Criteria in Solid Tumors Group and integrated into the present guidelines.
Journal ArticleDOI
EASL-EORTC clinical practice guidelines : management of hepatocellular carcinoma
Peter R. Galle,Alejandro Forner,Josep M. Llovet,Vincenzo Mazzaferro,Fabio Piscaglia,Jean-Luc Raoul,Peter Schirmacher,Valérie Vilgrain +7 more
TL;DR: The following Clinical Practice Guidelines will give up-to-date advice for the clinical management of patients with hepatocellular carcinoma, as well as providing an in-depth review of all the relevant data leading to the conclusions herein.
Journal ArticleDOI
Reporting results of cancer treatment.
TL;DR: Recommendations have been developed for standardized approaches to the recording of baseline data relating to the patient, the tumor, laboratory and radiologic data, the reporting of treatment, grading of acute and subacute toxicity, reporting of response, recurrence and disease‐free interval, and reporting results of therapy.
Journal ArticleDOI
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Jordi Bruix,Morris Sherman,Josep M. Llovet,Michel Beaugrand,Riccardo Lencioni,Andrew K. Burroughs,Erik Christensen,Luigi Pagliaro,Massimo Colombo,Juan Rodés +9 more
Journal ArticleDOI
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
TL;DR: A group of experts developed a set of guidelines aimed at providing a common framework for the design of clinical trials in HCC and adapted the concept of viable tumor-tumoral tissue showing uptake in arterial phase of contrast-enhanced radiologic imaging techniques-to formally amend RECIST, referred to herein as the modified RECIST assessment (mRECIST).